影响因子:4.6 年发文量:44 癌症药物耐药性SCIE Cancer Drug Resistance ISSN:2578-532X E-ISSN:暂无数据 是否OA:未开放 出版地区:暂无数据 创刊时间:暂无数据 是否预警:否 出版周期:暂无数据 语言:English 研究方向:ONCOLOGY 《癌症药物耐药性》(Cancer Drug Resistance)是一本以ONCOLOGY综合研究为特色的国际期刊。
Cancer Drug ResistancePubMedCAESCIJCR:Q1 发文量773 被引量49 影响因子(2023)0.099 《癌症耐药(英文)》是2018年由OAE Publishing Inc创办的一本金色开放获取季刊,也是目前唯一一本专注于癌症耐药领域的英文期刊。目前该期刊由Godefridus J. Peters教授担任主编,编委团队是由59名来自国内外该领域内的知名专家组成。
出版信息: 出版语言:English 出版商:OAE Publishing Inc. 评价信息: JCR分区:Q1 影响因子:4.6 CiteScore:6.6 投稿咨询 加急咨询 杂志介绍 JCR分区 CiteScore 投稿经验 杂志介绍 Cancer Drug Resistance杂志介绍 《Cancer Drug Resistance》是一本以English为主的未开放获取国际优秀期刊,中文名称癌症药物耐药性,本刊主...
Journal of Hematology&Oncology近几年影响因子分数几乎保持着直线上升,2016年6.263分,2017年6.35分,2018年7.333分,2019年8.731分,2020年11.058分,2021年17.388分,2022年最新影响因子,首次突破20分,高达23.168分,相较于上一年影响因子涨幅超33%。 数据来源:web of science 目前,这本杂志2020,2021年的文章在2022年的...
Molecular Cancer Therapeutics strives to be the top choice for publishing the best science in the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug ...
影响因子(2023) 11.171BBA Reviews on Cancer covers the whole field of the biology and biochemistry of cancer, emphasizing oncogenes and tumor suppressor genes, growth-related cell cycle control signalling, carcinogenesis mechanisms, cell transformation, immunologic control mechanisms, genetics of human (ma...
原名:Noncoding RNAs in gastric cancer: implications for drug resistance 译名:胃癌中的非编码RNA:对耐药性的影响法 期刊:Molecular Cancer 影响因子:10.679 发表时间:2020年3月19日 通讯作者:杨明 通讯作者单位:山东省第一医科大学 DOI:10.1186/s12943-020-01185-7 ...
影响因子(2023) 5.513Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers, ...
影响因子(2023)2.715 Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular an...
Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery ...